[{"address1": "2265 Upper Middle Road East", "address2": "Suite 602", "city": "Oakville", "state": "ON", "zip": "L6H 0G5", "country": "Canada", "phone": "289 910 0850", "fax": "905 481 2394", "website": "https://www.cardiolrx.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the developing of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38 injection for subcutaneous administration that is in preclinical development for the treatment of heart failure. It has a license agreement with Meros. The company was incorporated in 2017 and is headquartered in Oakville, Canada.", "fullTimeEmployees": 18, "companyOfficers": [{"maxAge": 1, "name": "Mr. David G. Elsley MBA", "title": "President, CEO & Director", "fiscalYear": 2024, "totalPay": 572568, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Christopher J. Waddick C.A., C.M.A., CPA, CMA, MBA", "title": "CFO, Corporate Secretary & Director", "fiscalYear": 2024, "totalPay": 223938, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Bernard  Lim B.Sc.", "title": "Chief Operating Officer", "fiscalYear": 2024, "totalPay": 391891, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Andrew Warwick Hamer M.D.", "age": 62, "title": "Chief Medical Officer and Head of Research & Development", "yearBorn": 1962, "fiscalYear": 2024, "totalPay": 572650, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Trevor  Burns", "title": "Investor Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John A. Geddes BSCPT, MBA", "title": "Vice President of Corporate Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 10, "boardRisk": 3, "compensationRisk": 10, "shareHolderRightsRisk": 3, "overallRisk": 9, "governanceEpochDate": 1754006400, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.34, "open": 1.36, "dayLow": 1.3, "dayHigh": 1.4199, "regularMarketPreviousClose": 1.34, "regularMarketOpen": 1.36, "regularMarketDayLow": 1.3, "regularMarketDayHigh": 1.4199, "payoutRatio": 0.0, "beta": 0.788, "forwardPE": -4.225806, "volume": 2192043, "regularMarketVolume": 2192043, "averageVolume": 551211, "averageVolume10days": 1883750, "averageDailyVolume10Day": 1883750, "bid": 1.27, "ask": 1.37, "bidSize": 9, "askSize": 9, "marketCap": 109483248, "fiftyTwoWeekLow": 0.771, "fiftyTwoWeekHigh": 2.63, "fiftyDayAverage": 1.34052, "twoHundredDayAverage": 1.304915, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 87608592, "profitMargins": 0.0, "floatShares": 79599950, "sharesOutstanding": 82649696, "sharesShort": 1758626, "sharesShortPriorMonth": 1864695, "sharesShortPreviousMonthDate": 1751241600, "dateShortInterest": 1753920000, "sharesPercentSharesOut": 0.021300001, "heldPercentInsiders": 0.042919997, "heldPercentInstitutions": 0.087060004, "shortRatio": 4.88, "shortPercentOfFloat": 0.0221, "impliedSharesOutstanding": 83575000, "bookValue": 0.299, "priceToBook": 4.381271, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -35785320, "trailingEps": -0.35, "forwardEps": -0.31, "enterpriseToEbitda": -2.18, "52WeekChange": -0.3282051, "SandP52WeekChange": 0.15005577, "quoteType": "EQUITY", "currentPrice": 1.31, "targetHighPrice": 9.94428, "targetLowPrice": 7.9911723, "targetMeanPrice": 8.846154, "targetMedianPrice": 8.724583, "recommendationMean": 1.6, "recommendationKey": "buy", "numberOfAnalystOpinions": 4, "totalCash": 23292700, "totalCashPerShare": 0.282, "ebitda": -40190760, "totalDebt": 150660, "quickRatio": 3.05, "currentRatio": 3.261, "debtToEquity": 0.857, "returnOnAssets": -0.89032, "returnOnEquity": -1.9011, "freeCashflow": -13604821, "operatingCashflow": -25291840, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "CAD", "symbol": "CRDL", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "shortName": "Cardiol Therapeutics Inc.", "longName": "Cardiol Therapeutics Inc.", "postMarketTime": 1755302147, "regularMarketTime": 1755288001, "exchange": "NCM", "messageBoardId": "finmb_424954803", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -2.23881, "regularMarketPrice": 1.31, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1547562600000, "postMarketChangePercent": 0.0, "postMarketPrice": 1.31, "postMarketChange": 0.0, "regularMarketChange": -0.0300001, "regularMarketDayRange": "1.3 - 1.4199", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 551211, "fiftyTwoWeekLowChange": 0.5389999, "fiftyTwoWeekLowChangePercent": 0.699092, "fiftyTwoWeekRange": "0.771 - 2.63", "fiftyTwoWeekHighChange": -1.3200002, "fiftyTwoWeekHighChangePercent": -0.5019012, "fiftyTwoWeekChangePercent": -32.82051, "earningsTimestampStart": 1763064000, "earningsTimestampEnd": 1763064000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.35, "epsForward": -0.31, "epsCurrentYear": -0.42, "priceEpsCurrentYear": -3.1190476, "fiftyDayAverageChange": -0.030520082, "fiftyDayAverageChangePercent": -0.022767344, "twoHundredDayAverageChange": 0.0050849915, "twoHundredDayAverageChangePercent": 0.0038967992, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-08-10", "averageAnalystRating": "1.6 - Buy", "marketState": "CLOSED", "hasPrePostMarketData": true, "displayName": "Cardiol Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-08-16"}]